Erudio Healtherudio.com
Sponsor
The Netherlands Cancer Institute trials: what clinicians said in public
No HCP commentary report on a trial sponsored by The Netherlands Cancer Institute yet. Erudio has found public clinician commentary on 20 clinical trials sponsored by The Netherlands Cancer Institute, including DEMETER, NICHE, OpACIN-neo and TRAIN-2. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
Listed by lead sponsor as registered on ClinicalTrials.gov (The Netherlands Cancer Institute). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| NICHE NCT03026140 · The Netherlands Cancer Institute DeepView → | early-stage colon cancer | Phase 2 | Deep | View | |||
| TRAIN-2 NCT01996267 · The Netherlands Cancer Institute DeepView → | HER2-positive breast cancer | Phase 3 | Deep | View | |||
| DEMETER NCT07786051 · The Netherlands Cancer Institute DeepView → | ER-positive HER2-negative metastatic breast cancer | Phase 2 | Deep | View | |||
| OpACIN-neo NCT02977052 · The Netherlands Cancer Institute DeepView → | macroscopic stage III melanoma | Phase 2 | Deep | View | |||
| PERICLES NCT03686332 · The Netherlands Cancer Institute DeepView → | advanced squamous cell carcinoma of the penis | Phase 2 | Deep | View | |||
| NESCIO NCT05148546 · The Netherlands Cancer Institute DeepView → | resectable clear cell renal cell carcinoma | Phase 2 | Deep | View | |||
| INDIBLADE NCT05200988 · The Netherlands Cancer Institute DeepView → | muscle-invasive bladder cancer | Phase 2 | Deep | View | |||
| NEOAVAX NCT03341845 · The Netherlands Cancer Institute DeepView → | moderate- to high-risk localized clear-cell renal cell carcinoma | Phase 2 | Deep | View | |||
| PEMBRO-RT NCT02492568 · The Netherlands Cancer Institute StandardView → | advanced non-small cell lung cancer | Phase 2 | Standard | View | |||
| MATISSE NCT04620200 · The Netherlands Cancer Institute StandardView → | resectable advanced cutaneous squamous cell carcinoma | Phase 2 | Standard | View | |||
| NADINA NCT04949113 · The Netherlands Cancer Institute StandardView → | macroscopic resectable stage III melanoma | Phase 3 | Standard | View | |||
| CRITICS-II NCT02931890 · The Netherlands Cancer Institute StandardView → | resectable gastric cancer | Phase 2 | Standard | View | |||
| OpACIN NCT02437279 · The Netherlands Cancer Institute StandardView → | stage III skin melanoma | Phase 1 | Standard | View | |||
| NivoMes NCT02497508 · The Netherlands Cancer Institute FocusedView → | recurrent malignant pleural mesothelioma | Phase 2 | Focused | View | |||
| PEMMELA NCT04287829 · The Netherlands Cancer Institute FocusedView → | second-line and third-line malignant pleural mesothelioma | Phase 2 | Focused | View | |||
| HA-PCI NCT01780675 · The Netherlands Cancer Institute FocusedView → | small cell lung cancer | Phase 3 | Focused | View | |||
| TATIN NCT04148066 · The Netherlands Cancer Institute FocusedView → | Not given | Not applicable | Focused | View | |||
| OVHIPEC-2 NCT03772028 · The Netherlands Cancer Institute FocusedView → | FIGO stage III epithelial ovarian cancer | Phase 3 | Focused | View | |||
| TRAEMOS NCT03784599 · The Netherlands Cancer Institute FocusedView → | EGFR mutation-positive NSCLC with HER2 bypass track resistance | Phase 2 | Focused | View | |||
| NCT02324452 NCT02324452 · The Netherlands Cancer Institute FocusedView → | Not given | Not applicable | Focused | View | |||